The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

about

The Antioxidant Procyanidin Reduces Reactive Oxygen Species Signaling in Macrophages and Ameliorates Experimental Colitis in Mice.

P2860

Q49278089-799A03B2-8138-4370-8C30-A6900993400A

P2860

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

Item

http://www.wikidata.org/entity/Q42375644

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The prognostic value of histol ...... ical remission with mesalazine

@en

The prognostic value of histol ...... ical remission with mesalazine

@nl

type

Item

label

The prognostic value of histol ...... ical remission with mesalazine

@en

The prognostic value of histol ...... ical remission with mesalazine

@nl

prefLabel

The prognostic value of histol ...... ical remission with mesalazine

@en

The prognostic value of histol ...... ical remission with mesalazine

@nl

P1476

The prognostic value of histol ...... ical remission with mesalazine

@en

P2093

Annalisa Capannolo

http://www.w3.org/2001/XMLSchema#string

Brigida Galletti

http://www.w3.org/2001/XMLSchema#string

Donatella Serva

http://www.w3.org/2001/XMLSchema#string

Giovanni Latella

http://www.w3.org/2001/XMLSchema#string

Giuseppe Frieri

http://www.w3.org/2001/XMLSchema#string

Laura Sollima

http://www.w3.org/2001/XMLSchema#string

Mirko Di Ruscio

http://www.w3.org/2001/XMLSchema#string

Pietro Leocata

http://www.w3.org/2001/XMLSchema#string

Rachele Tittoni

http://www.w3.org/2001/XMLSchema#string

Rosamarie Frieri

http://www.w3.org/2001/XMLSchema#string

P2860

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

Review article: defining remission in ulcerative colitis

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.

Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.

High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: results of a meta-analysis of clinical trials.

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.

P304

749-759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756283X17722926

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Angelo Viscido

P577

2017-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29051786

http://www.w3.org/2001/XMLSchema#string

P932

5638180

http://www.w3.org/2001/XMLSchema#string

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

about

P2860

P2860

The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932